Arjuna

What is Arjuna?

Arjuna (Terminalia arjuna) is a large deciduous tree in the Combretaceae family, native to the river valleys of the Indian subcontinent, where it sheds its pale grey bark in curling scales. That bark is the medicine. Unlike almost every other Ayurvedic cardiac herb, arjuna has been through real randomized human trials, including a double-blind crossover study in 58 men with chronic stable angina that gave 500 mg of bark preparation every eight hours and compared it head to head against isosorbide mononitrate. That is an unusual evidence base for a traditional botanical, and also the source of most of the confusion about what is in the bottle.

Arjuna occupies a specific niche in Ayurveda as a hridya dravya, a heart substance. Vagbhata described a milk decoction of the bark for heart disease in the Ashtanga Hridaya around the seventh century CE, and Chakradatta described bark preparations with milk and ghee some four hundred years later. Claims of thousands of years of cardiac use are not supportable from those texts.

Common Names

• Arjuna, arjun, arjun chaal (bark)

• Arjuna myrobalan

• White marudah, white murdh

• Kahua (Hindi)

Primary Active Compounds

• Arjunolic acid, arjunic acid, and arjungenin (pentacyclic triterpenoids)

• Arjunetin and arjunoside (triterpenoid glycosides)

• Triterpenoid saponins, proposed as the inotropic fraction

• Hydrolysable tannins including casuarinin, punicalagin, and castalagin

• Flavonoids including arjunone, arjunolone, and luteolin

• Notable minerals, with published bark analyses reporting roughly 3,100 micrograms per gram of calcium and 4,000 of magnesium

Key Note

The traditional milk decoction and a modern alcohol extract do not pull the same chemistry out of the bark. Ksheerpak is a water and milk-fat extraction, favoring tannins, water-soluble glycosides, and minerals, with milk lipids carrying the less soluble triterpenoids. An ethanolic extract concentrates a different fraction. When a review says arjuna improved ejection fraction, ask which preparation was tested.

Arjuna is one of the few botanicals sold directly to people with diagnosed cardiac disease, which raises the stakes on every claim made about it.

Primary Functions & Benefits

Myocardial Contractility

• Saponin glycosides are the fraction credited with a mild positive inotropic effect

• Studied in heart failure protocols for ejection fraction and left ventricular dimensions

Anginal and Ischemic Support

• Reduced angina frequency and nitroglycerin use in small randomized trials

• Improved treadmill exercise duration and reduced exercise-induced ST depression

• Proposed coronary vasodilation and improved myocardial oxygen economy

Antioxidant Protection of Cardiac Tissue

• Flavonoids and phenolics raise endogenous myocardial antioxidant capacity and reduce cardiac lipid peroxidation in animal ischemia models

Lipid and Vascular Effects

• Modest total and LDL cholesterol reductions in small trials, with HMG-CoA reductase inhibition proposed as one route

• Improved flow-mediated dilation reported in a study of chronic smokers

• Reduced hsCRP, IL-6, and TNF-alpha in a six-month placebo-controlled study of patients already on cardiac medication

Who Should Take Arjuna

• People with stable cardiac disease who want an adjunct on top of guideline-directed therapy, with cardiologist sign-off

• Those under an Ayurvedic practitioner using a traditional ksheerpak rather than a generic capsule

• People with mildly elevated lipids looking for a botanical contribution alongside diet change

• Anyone who can arrange baseline and follow-up liver enzymes and a thyroid panel

Who Should AVOID or Use Caution

Contraindications

• Anyone considering it as a substitute for prescribed cardiac medication. This is the real contraindication and it dwarfs the rest.

• Pregnancy and breastfeeding, where safety data are absent

• Known allergy to Combretaceae plants

• Unevaluated or unstable cardiac symptoms, where self-treating delays diagnosis

Use Caution

• People on antihypertensive drugs, given additive blood pressure lowering

• People on digoxin or another cardiac glycoside, where an added inotropic and mineral load is not trivial

• People with hypothyroidism or on levothyroxine, based on a preliminary animal signal

• People with liver disease, or on anticoagulants or antiplatelet drugs

• Anyone scheduled for surgery, who should stop well in advance

Critical Safety Point

Angina, hypertension, and heart failure are conditions where treatment choice changes survival. Every arjuna trial worth citing added the bark to conventional therapy in patients who stayed on it, and none tested arjuna as a replacement for a beta blocker, a statin, an ACE inhibitor, or a diuretic. Chest pain that is new, worsening, at rest, or lasting more than a few minutes is an emergency, not a dosing question. Tell your cardiologist you are taking it, because a botanical that moves a number without appearing on the chart makes your care harder to titrate.

Recommended Dosages

Bark Powder (Churna), the traditional form

• Ayurvedic practice commonly uses 1 to 3 grams daily, often split

• Prepared as ksheerpak by simmering the powder in milk and water until the water is gone

Capsules of Crude Bark Powder

• Trial-equivalent dosing is 500 mg three times daily, totaling 1,500 mg

• Most retail products deliver 250 to 500 mg once or twice daily, far below that

Standardized Extracts

• Ratios of 4:1 to 10:1 are common, so the milligram number on the bottle is not comparable to a crude powder number

• Where a marker is declared it is usually arjunolic acid or total tannins, sometimes as little as 5 mg per serving, and many products declare none at all

Duration

• Angina crossover phases ran one week; post-infarction and lipid work ran 30 days to 3 months; the longest controlled trial ran 6 months

• No controlled safety data exists for continuous use beyond about a year

Timing & Administration

Split the Dose

• The eight-hourly schedule used in the trials is not decorative. Three divided doses is what was tested.

With Milk, If Following Tradition

• Ksheerpak is the classical vehicle, and milk fat plausibly improves triterpenoid delivery

Away From Thyroid Medication

• Separate arjuna from levothyroxine by at least four hours given the tannin content and the thyroid signal

With Food If It Upsets You

• Gastric discomfort, nausea, and constipation usually ease when it is taken with a meal

Monitor, Do Not Guess

• If you take it for lipids or blood pressure, get a before and after number

Benefits of Taking Arjuna

• One of the very few Ayurvedic cardiac herbs with randomized human data rather than tradition alone

• Reduced angina episodes and nitroglycerin use in small controlled trials

• Improved exercise tolerance and reduced exercise-induced ST depression

• Reported ejection fraction improvements when added to conventional heart failure treatment

• Modest total and LDL cholesterol reduction

• Lower circulating inflammatory markers in patients already on cardiac medication

• Well tolerated, with trial adverse event rates similar to placebo

Potential Negatives & Side Effects

• Gastric irritation, nausea, and constipation, the most frequently reported complaints

• Headache and body ache, at rates close to placebo

• Additive hypotension alongside blood pressure medication, felt as dizziness on standing

• A slower resting heart rate in some users

• Possible thyroid hormone suppression, from rodent rather than human data

• Isolated reports of liver enzyme elevation with Terminalia preparations, plus increased hepatic lipid peroxidation at the higher dose in a rat study

• The largest practical risk is not a side effect. It is the false reassurance of feeling covered while a cardiac condition goes undertreated.

Deficiency Symptoms

Arjuna is a plant medicine with a narrow cardiac indication. Your body has no requirement for it, no store of it, and no failure state arising from its absence, so there is no such thing as arjuna deficiency.

What arjuna addresses

• Symptomatic burden in stable angina, meaning episode frequency and rescue nitrate use, as an add-on to standard treatment

• Oxidative stress in myocardial tissue, measured mostly in animal models

• Elevated LDL cholesterol, modestly

• Endothelial dysfunction, in preliminary human work

Bottom line

Nobody has an arjuna gap. The question is whether adding it to an already appropriate cardiac regimen improves anything measurable, and the honest answer is that the trials suggesting yes are small and the meta-analysis that pooled them could not confirm it.

Toxicity Symptoms

Rodent studies found no toxicity from bark extract at 2,000 mg per kilogram, orders of magnitude above human use. The realistic concerns are chronic and pharmacological rather than acute.

At high intake

• Symptomatic low blood pressure and excessive slowing of heart rate, particularly alongside antihypertensives

• Rising liver transaminases, suggested by rodent data and scattered Terminalia case reports

• Suppressed thyroid hormone, seen in rats at doses the investigators called comparable in effect to propylthiouracil

Signs to reduce or stop

• Lightheadedness, fainting, or a resting pulse well below your usual

• Fatigue, cold intolerance, or weight gain suggesting a thyroid shift

• Right upper abdominal discomfort, dark urine, or yellowing of the skin or eyes

• Hives, swelling, or breathing difficulty suggesting sensitivity to the plant

General note

A single large accidental dose is unlikely to hurt anyone. Sustained high-dose use without monitoring is the pattern to avoid, and the organs to watch are the liver and the thyroid.

How Arjuna Works

Inotropic Action

• Triterpenoid saponin glycosides are credited with increasing the force of myocardial contraction, which is why reviews compare arjuna to digitalis. The comparison overstates potency but describes the direction.

Coronary Vasodilation and Oxygen Economy

• Improved coronary flow and lower myocardial oxygen demand are the proposed explanation for less ST depression on treadmill testing

Myocardial Antioxidant Support

• Flavonoids and phenolics raise endogenous antioxidant enzyme activity and reduce lipid peroxidation in ischemia models

Mild ACE Inhibition

• Extracts inhibit angiotensin converting enzyme in vitro, though nowhere near the potency of a prescription ACE inhibitor

Lipid, Endothelial, and Anti-inflammatory Effects

• Proposed HMG-CoA reductase inhibition and lipoprotein lipase effects, both largely preclinical, alongside reduced VCAM-1 and E-selectin expression, lower TNF-alpha, and improved nitric oxide mediated dilation

Synergistic Supplements

For Cardiac Energetics

• CoQ10 - mitochondrial ATP production in myocardium, the most rational pairing

• L-carnitine - fatty acid transport into cardiac mitochondria

• Magnesium - membrane stabilization

For Lipids

• Plant sterols and soluble fiber - independent mechanisms for LDL reduction

• Omega-3 fatty acids - triglyceride reduction

For Vascular Tone

• Hawthorn (Crataegus) - the closest Western analogue to arjuna, with overlapping cardiac effects and therefore overlapping hypotensive risk

• Beetroot or dietary nitrate - vasodilation through a separate pathway

• Ashwagandha - studied alongside arjuna in Indian exercise performance work

Interactions & What NOT to Take

Antihypertensive Medication

• Beta blockers, ACE inhibitors, ARBs, calcium channel blockers, and diuretics can all be potentiated. Monitor at home.

Digoxin and Cardiac Glycosides

• Arjuna's inotropic action and mineral content overlap with digoxin's therapeutic territory. Digoxin has a narrow therapeutic index, so this pairing belongs under prescriber supervision only.

Thyroid Medication

• Rat work found arjuna bark extract lowered thyroid hormone levels, with effects the investigators compared to propylthiouracil. No human confirmation exists, but anyone on levothyroxine should separate doses and recheck TSH.

Anticoagulants and Antiplatelet Drugs

• Laboratory work describes antiplatelet and anticoagulant activity. Combine with warfarin, apixaban, clopidogrel, or high-dose aspirin only with medical oversight.

Drugs Metabolized by CYP3A4, CYP2D6, and CYP2C9

• Extracts inhibited these enzymes in vitro. The clinical significance is unestablished, but the list of cardiac drugs cleared by CYP3A4 is long.

Hepatotoxic Drugs and Red Yeast Rice

• Given the liver signal, stacking arjuna with anything else that stresses the liver is a poor idea

Special Considerations

Not Haritaki, Not Bibhitaki

• Terminalia arjuna is a different medicine from Terminalia chebula (haritaki) and Terminalia bellirica (bibhitaki), the two Terminalia species that combine with amla to make triphala. Those are fruits used as digestive and eliminative medicines. Arjuna is a bark used for the heart. See our earlier issues on haritaki and triphala. Sharing a genus does not make them interchangeable, and some suppliers are careless about which they ship.

Bark Sourcing and Heavy Metals

• Bark regenerates when stripped correctly, but demand has pressured wild stands, which makes adulteration with related species a real quality issue. Bark also concentrates soil minerals, which is why the calcium and magnesium content is notable and why heavy metal testing matters here.

Preparation Matters More Here Than Usual

• A milk decoction, a water extract, and an ethanolic extract are three different products, and the heart failure and angina trials mostly used aqueous preparations. Fermented formulations such as Arjunarishta contain alcohol and other herbs and are not equivalent.

Research Status & Evidence Quality

Strong Evidence For

• Nothing meets a strong evidence standard. There is no large multicenter randomized trial of arjuna with hard cardiovascular endpoints.

Moderate Evidence For

• Reduced angina frequency and nitrate requirement when added to standard therapy in small randomized trials

• Improved treadmill duration and reduced exercise-induced ST depression

• Short-term tolerability, with adverse event rates comparable to placebo

Emerging / Preliminary Evidence For

• Improved ejection fraction in heart failure and after myocardial infarction

• Total and LDL cholesterol reduction

• Reduced hsCRP, IL-6, and TNF-alpha

• Improved endothelial function

• Thyroid hormone suppression and hepatic effects, both rodent work only

Research Limitations

• Nearly all of the clinical work is small, single-center, short, and Indian, and none of it has been replicated by independent groups elsewhere. The 2014 systematic review and meta-analysis in chronic stable angina judged the included studies to be of poor methodological design, found no significant difference from control in the outcomes it could pool, and concluded the evidence was insufficient to decide for or against arjuna. Crossover phases as short as one week cannot speak to mortality or hospitalization. Preparations varied and were often poorly characterized. And every trial gave arjuna as an adjunct, so the literature contains no evidence at all about arjuna used alone.

Summary & Key Takeaways

Arjuna is the most seriously studied cardiac herb in the Ayurvedic pharmacopeia, which is a lower bar than it sounds. The trials are real and some results are interesting, particularly the angina work and the six-month drop in inflammatory markers. But they are small, they come from one country and often one center, the meta-analysis that pooled them came back empty, and every one of them gave arjuna on top of conventional treatment. The bark is a plausible adjunct with a reasonable safety record, not a treatment.

Bottom Line

The studied exposure is 500 mg three times a day of a bark preparation, not 500 mg once daily of an unspecified extract, and it belongs alongside your cardiologist's plan rather than in place of it. If the label gives you neither the extraction solvent nor the ratio nor a marker compound, you cannot know what you bought.

Key Safety Points

Never substitute arjuna for prescribed cardiac medication. It adds to the effect of blood pressure drugs and overlaps with digoxin's mechanism, so both combinations need prescriber oversight. Rodent data show thyroid hormone suppression and, at higher doses, increased hepatic lipid peroxidation, so monitor if you are on levothyroxine or have liver disease. Avoid in pregnancy and breastfeeding, and stop before surgery.

Special Note

When a botanical is marketed for a serious diagnosed condition, check two things first: what dose the trials used, and whether the subjects stayed on their real medication. For arjuna the answers are 1,500 mg daily in divided doses, and yes, every time. Bottles quiet about that second answer are selling something the research never tested.